matrixassist
laser
desorpt
mass
spectrometri
malditof
ms
analyt
method
microbi
identif
character
base
fast
precis
assess
mass
molecul
variabl
rang
kda
first
descript
use
ms
technolog
bacteri
identif
furthermor
malditof
ms
use
identif
bacteria
research
set
took
long
time
introduct
technolog
routin
microbiolog
first
complet
databas
bacteri
identif
report
possibl
malditof
quickli
character
wide
varieti
microorgan
includ
bacteria
fungi
virus
increas
potenti
applic
area
microbiolog
diagnosi
thu
technolog
use
rapid
microbi
identif
rel
low
cost
altern
convent
laboratori
diagnosi
molecular
identif
system
major
contribut
method
drastic
improv
time
identif
posit
sampl
main
use
technolog
identif
type
bacteria
posit
cultur
howev
applic
field
clinic
virolog
also
perform
open
new
opportun
although
introduct
routin
laboratori
diagnosi
still
remain
challeng
review
malditof
techniqu
present
includ
sampl
prepar
well
data
manag
qualiti
control
mainli
focus
viral
research
diagnosi
mass
spectromet
compos
three
main
compon
ion
sourc
ioniz
transfer
sampl
molecul
ion
ga
phase
mass
analyz
devic
separ
molecul
depend
mass
final
detector
monitor
separ
ion
sever
ioniz
method
chemic
ioniz
electrospray
maldi
choic
method
basic
depend
object
ms
analysi
natur
sampl
although
maldi
electrospray
techniqu
permit
ioniz
vapor
big
quantiti
biomolecul
ms
techniqu
sampl
prepar
mix
sever
biomolecul
embed
matrix
crystal
insid
matrix
compos
small
acid
molecul
strong
optic
absorpt
rang
laser
wavelength
use
although
composit
differ
accord
type
laser
use
biomolecul
analyz
molecul
desorb
ioniz
charg
transfer
absorb
energi
short
laser
puls
desorb
ioniz
molecul
first
acceler
electr
field
eject
metal
flight
tube
collid
detector
end
flight
tube
cycl
repeat
frequenc
hz
thu
biomolecul
separ
accord
mass
creat
mass
spectrum
character
mass
intens
ion
final
result
spectral
signatur
spike
represent
search
appropri
databas
identif
microorgan
compar
valu
provid
manufactur
databas
hand
electrospray
ioniz
mass
spectrometri
esim
gener
use
dna
amplicon
dissolv
solvent
inject
conduct
capillari
insid
capillari
high
voltag
appli
result
emiss
aerosol
charg
drop
sampl
sampl
spray
compart
diminish
pressur
result
format
gasphas
multiplecharg
analyt
ion
final
detect
spectromet
esim
technolog
permit
high
resolut
analyz
basic
composit
amplicon
also
two
avail
method
type
use
technolog
first
method
maldiresequenc
use
iseq
method
techniqu
rna
strand
cleav
product
cleavag
analyz
ms
spectra
compar
spectra
refer
sequenc
initi
maldir
use
mainli
detect
singlenucleotid
polymorph
current
addit
applic
method
second
method
type
base
use
esi
technolog
analyz
specif
dna
amplicon
pcresim
virus
tradit
detect
cell
cultur
spite
gold
standard
often
took
day
even
week
result
avail
common
laboratori
techniqu
virus
detect
includ
antibodi
analysi
enzymelink
immunosorb
assay
molecular
techniqu
like
polymeras
chain
reaction
pcr
dot
blot
hybrid
howev
malditof
technolog
alreadi
use
investig
wide
varieti
virus
clinic
relev
advanc
less
bacteriolog
mycolog
sever
approach
technolog
applic
field
virolog
recent
studi
perform
multiplex
malditof
ms
method
success
detect
human
herp
virus
wide
varieti
archiv
biolog
specimen
concord
rate
malditof
ms
techniqu
refer
method
high
detect
limit
ms
method
compar
previou
report
multiplex
herp
viru
detect
use
oligonucleotid
microarray
multiplex
pcr
techniqu
low
viral
load
near
detect
limit
method
weak
crossreact
might
contribut
discrep
result
refer
method
thu
multiplex
approach
use
largescal
epidemiolog
research
studi
broad
virus
detect
necessari
may
also
becom
highli
use
multiplex
clinic
diagnost
test
rapid
identif
exist
emerg
respiratori
virus
crucial
combat
outbreak
epidem
detect
respiratori
virus
influenza
virus
mainli
perform
use
pcr
techniqu
realtim
revers
transcript
polymeras
chain
reaction
rrtpcr
antibodybas
assay
identifi
nucleoprotein
altern
method
investig
viral
diagnosi
multiplex
flow
cytometri
microarray
ms
ms
consid
one
best
method
protein
analysi
low
detect
limit
high
accuraci
also
demonstr
combin
use
antibodymagnet
nanoparticl
malditof
ms
suitabl
sensit
detect
influenza
virus
method
could
also
use
rapid
screen
viru
subtyp
suggest
promis
applic
earli
accur
diagnosi
influenza
virus
develop
rapid
sampl
prepar
method
allow
identif
cultur
respiratori
virus
ms
multiplex
pcr
coupl
techniqu
detect
common
respiratori
virus
influenza
viru
parainfluenza
virus
coronaviru
metapneumoviru
respiratori
syncyti
viru
adenoviru
bocaviru
enterovirus
also
major
caus
ill
children
caus
gastroenter
hand
foot
mouth
diseas
sever
neurolog
complic
asept
mening
enceph
acut
neurogen
pulmonari
edema
classic
detect
enter
viru
mostli
base
convent
approach
indirect
immunofluoresc
assay
neutral
test
cell
cultur
immunohistochem
detect
howev
clinic
sampl
remain
undetect
absenc
antibodi
viral
protein
cell
cultur
neutral
test
timeconsum
labori
multiplex
rtpcr
realtim
pcr
shown
good
sensit
specif
virus
malditof
ms
technolog
demonstr
high
capac
diagnos
high
throughput
short
turnaround
time
malditof
ms
measur
intrins
physic
properti
molecul
directli
pcr
mass
assay
combin
multiplex
pcr
malditof
ms
technolog
shown
simultan
detect
eight
human
enter
virus
includ
polioviru
coxsackieviru
enteroviru
hepat
e
viru
echoviru
noroviru
astroviru
reoviru
method
sensit
rang
copi
per
reaction
show
assay
could
use
simultan
detect
coinfect
sever
virus
malditof
ms
also
use
diagnosi
hand
foot
mouth
diseas
caus
acut
enteroviru
infect
polioviru
coxsackieviru
b
echoviru
infect
clinic
indistinguish
infect
echoviru
could
complic
asept
mening
enceph
acut
flaccid
paralysi
recent
studi
develop
malditof
ms
techniqu
rapid
diagnosi
virus
diagnosi
pathogen
help
comprehens
surveil
enterovirus
understand
molecular
epidemiolog
enterovirus
detect
multipl
genotyp
simultan
main
advantag
strategi
identif
sever
genotyp
time
open
new
possibl
diagnosi
discov
patholog
epidemiolog
characterist
hand
infect
highrisk
human
papillomavirus
hpv
close
associ
cervic
cancer
well
type
cancer
anu
vagina
peni
head
neck
diagnosi
hpv
infect
base
sever
method
hpv
dna
detect
necessari
followup
patient
current
three
hpv
assay
approv
clinic
use
us
food
drug
administr
two
nonpcrbas
assay
eg
cervista
holog
marlborough
hybrid
captur
qiagen
valencia
ca
pcrbase
method
coba
hpv
assay
major
assay
use
consensu
primer
primer
multiprim
deriv
primer
system
howev
new
method
base
amplif
fragment
gene
region
use
consensu
primer
use
mass
array
techniqu
base
malditof
ms
technolog
recent
develop
identifi
highrisk
hpv
ms
assay
found
noncrossreact
common
lowrisk
hpv
genotyp
affect
genit
tract
sensit
gener
sensit
result
rang
copi
hybrid
captur
convent
pcr
method
advantag
method
possibl
extend
hpv
genotyp
spectrum
ad
new
typespecif
primer
use
techniqu
togeth
autom
dna
extract
pcr
pipet
procedur
could
increas
viral
detect
decreas
cost
overal
assay
hepat
b
viru
hbv
hepat
c
viru
hcv
infect
still
major
public
health
problem
due
worldwid
morbid
mortal
reason
screen
infect
import
part
routin
laboratori
activ
serolog
molecular
marker
key
element
diagnosi
prognosi
monitor
treatment
hbv
hcv
infect
current
chemiluminesc
assay
wide
use
viral
diagnosi
molecular
techniqu
routin
use
detect
quantifi
viral
genom
analyz
sequenc
determin
genotyp
detect
resist
antivir
drug
howev
massarray
system
base
nucleic
acid
analysi
malditof
ms
technolog
provid
altern
approach
hbv
hcv
genotyp
accur
identifi
eight
hbv
genotyp
massarray
system
gener
ms
pattern
compar
sequenc
deriv
known
hbv
genotyp
main
advantag
assay
rapid
costeffect
versatil
assay
produc
automat
data
report
requir
addit
data
interpret
moreov
method
discrimin
singlepoint
mutat
capabl
detect
wildtyp
mutant
allel
variat
hbv
genom
biolog
clinic
import
might
confer
drug
resist
affect
viru
replic
capac
result
failur
antivir
therapi
malditof
ms
platform
capabl
detect
hbv
variant
accuraci
low
detect
limit
technolog
use
also
studi
evolut
drug
resist
detect
minor
hbv
variant
main
disadvantag
method
hbv
genotyp
b
c
test
characterist
mutat
hbv
could
caus
lamivudin
resist
due
prolong
treatment
antivir
agent
current
method
detect
variant
eg
sequenc
analysi
restrict
fragment
length
polymorph
rflp
hybridizationbas
assay
timeconsum
unsuit
screen
larg
number
sampl
reason
develop
malditof
ms
assay
suitabl
detect
ymdd
mutant
techniqu
provid
high
rate
accuraci
ymdd
mutat
advantag
rflp
direct
dna
sequenc
includ
abil
sensit
specif
detect
mix
popul
well
simpler
procedur
without
need
clone
multipl
pcr
step
produc
earlier
detect
hbv
mutat
moreov
platform
adapt
detect
mutat
polymorph
method
use
evalu
emerg
mutant
virus
monitor
antivir
treatment
chronic
hepat
b
correl
clinic
featur
regard
respons
drug
therapi
patient
hand
identif
hcv
genotyp
becom
import
determin
clinic
cours
outcom
antivir
therapi
mani
hcv
genotyp
method
develop
includ
genotypespecif
pcr
rflp
hybrid
techniqu
heteroduplex
motil
assay
current
method
choic
purpos
nucleotid
sequenc
subgenom
region
method
complex
standard
laborintens
nonus
determin
multipl
hcv
genotyp
howev
frequent
heterogen
cours
infect
produc
mixedgenotyp
infect
patient
thu
research
develop
malditof
assay
hcv
genotyp
last
year
genotyp
purpos
ms
provid
accur
inform
molecular
mass
analyt
procedur
fulli
autom
well
direct
analysi
molecul
label
introduc
separ
step
follow
imag
process
method
base
malditof
ms
technolog
viral
diagnosi
purpos
also
recent
develop
method
base
malditof
ms
technolog
studi
possibl
genotyp
jc
viru
use
urin
sampl
patient
without
clinic
evid
progress
multifoc
leukoencephalopathi
malditof
show
success
genotyp
virus
identifi
sequenc
variat
target
genom
anoth
studi
use
techniqu
identifi
possibl
mutat
influenza
virus
monitor
purpos
final
applic
malditof
ms
techniqu
could
use
detect
drug
resist
antivir
recent
studi
develop
sensit
rapid
method
detect
ganciclovir
resist
pcrbase
malditof
analysi
potenti
applic
malditof
ms
technolog
provid
critic
epidemiolog
data
viral
infect
epidemiolog
point
view
one
main
applic
method
determin
specif
data
clinic
isol
viral
diseas
outbreak
complex
viral
type
techniqu
requir
special
test
method
addit
diagnost
devic
reason
type
routin
perform
everi
laboratori
sampl
sent
hospit
fact
could
delay
investig
outbreak
hospitalassoci
infect
introduct
malditof
ms
technolog
laboratori
facilit
perform
test
lead
improv
inform
infect
control
staff
introduct
ms
techniqu
clinic
laboratori
provid
accur
rapid
epidemiolog
data
could
critic
role
hospit
infect
control
surveil
viral
outbreak
regard
viral
diagnosi
studi
compar
malditof
ms
technolog
convent
base
method
eg
viral
cultur
nucleic
techniqu
malditof
method
success
detect
virus
wide
varieti
biolog
specimen
concord
rate
malditof
techniqu
high
pcrbase
identif
strategi
limit
much
longer
turnaround
time
ms
reagent
labor
cost
technic
problem
hand
malditof
technolog
also
use
identifi
virus
coinfect
sampl
method
capabl
simultan
detect
multipl
pathogen
singl
assay
prevent
misdiagnosi
delay
treatment
without
increas
cost
ad
new
step
process
regard
technic
problem
pcr
method
could
inhibitori
particl
issu
contamin
thu
separ
area
sampl
prepar
amplif
analysi
need
furthermor
nucleic
techniqu
expens
timeconsum
appear
case
less
conveni
ms
routin
laboratori
identif
malditof
must
signific
progress
made
screen
viral
subtyp
identif
antivir
resist
epidemiolog
viral
infect
close
upfront
pcr
process
includ
dna
extract
pcr
process
malditof
ms
method
also
allow
largescal
research
studi
fresh
sampl
also
archiv
sampl
sever
biolog
specimen
main
advantag
disadvantag
malditof
ms
technolog
shown
tabl
remark
differ
malditof
method
convent
techniqu
estim
time
cost
requir
sampl
identif
studi
costeffect
virus
estim
cost
bacteri
identif
repres
cost
convent
identif
method
studi
shown
cost
reagent
requir
phenotyp
nucleic
acid
identif
higher
ms
techniqu
expens
cost
malditof
devic
compar
laboratori
equip
moreov
malditof
rapid
techniqu
compar
method
technolog
improv
work
time
eg
preanalyt
procedur
well
turnaround
time
eg
analyt
procedur
time
need
microorgan
identif
minut
ms
method
wherea
convent
techniqu
need
hour
one
main
weak
malditof
identif
limit
databas
mass
profil
use
mass
spectrum
compar
wellcharacter
organ
databas
spectrum
typic
includ
specif
peak
comprehens
librari
spectra
identif
might
perform
use
bioinformat
current
wide
number
refer
databas
avail
commerci
platform
malditof
techniqu
mass
spectra
establish
comparison
identif
microorgan
spectra
limit
databas
expand
due
collabor
commerci
compani
hospit
sever
countri
avail
databas
improv
near
futur
comparison
data
differ
compani
instrument
import
fact
current
feasibl
sampl
prepar
malditof
ms
remain
labori
today
although
robot
develop
improv
deposit
sampl
matrix
target
moreov
aspect
malditof
ms
technolog
also
investig
exampl
laser
puls
frequenc
dispos
target
slide
mass
spectromet
well
softwar
use
commun
laboratori
equip
laboratori
inform
system
li
data
manag
primarili
depend
interpret
crude
data
current
method
data
interpret
investig
import
fact
integr
inform
commun
system
physician
requir
hospit
inform
system
li
refer
databas
requir
updat
new
inform
obtain
addit
new
isol
mutat
could
improv
tool
final
diagnosi
diseas
robust
system
inform
region
preval
infecti
diseas
emerg
reemerg
infecti
pathogen
discoveri
new
mutat
local
pandem
chang
epidemiolog
necessari
malditof
ms
system
increasingli
use
clinic
diagnost
laboratori
viral
identif
mutat
analysi
genotyp
antivir
resist
studi
howev
still
problem
aris
sampl
extract
affect
extract
protocol
adequ
reagent
conserv
assay
problem
could
avoid
introduct
adequ
qualiti
control
program
extract
step
daili
check
train
technician
well
introduct
routin
intern
qualiti
control
aspect
techniqu
must
submit
adequ
qualiti
control
deposit
sampl
micropl
clean
micropl
necessari
implement
control
issu
correct
identif
sampl
final
good
practic
devic
adequ
mainten
malditof
base
global
qualiti
control
program
sens
calibr
control
tool
use
recalibr
spectromet
devic
identifi
technic
problem
appropri
mainten
devic
essenti
carri
adequ
accur
viral
identif
essenti
continu
improv
qualiti
databas
introduc
qualiti
control
program
ms
devic
implement
program
help
improv
qualiti
overal
procedur
basi
improv
use
accuraci
malditof
malditof
ms
rel
recent
innov
identif
microorgan
use
mani
clinic
microbiolog
laboratori
main
applic
technolog
moment
identif
bacteria
speci
level
less
minut
although
method
becom
standard
identif
microorgan
laboratori
malditof
ms
technolog
also
introduc
virolog
assay
main
applic
field
identif
virus
clinic
sampl
discoveri
mutat
virus
rapid
screen
viru
subtyp
use
molecular
epidemiolog
detect
resist
sever
antivir
agent
futur
applic
malditof
ms
clinic
virolog
develop
provid
accur
identif
clinic
specimen
includ
detect
resist
protein
marker
specif
virul
sever
virus
howev
introduct
technolog
routin
virolog
diagnosi
would
enabl
chang
work
practic
moreov
fact
requir
complet
integr
laboratori
workflow
sever
technic
improv
detect
sensit
continu
updat
databas
microorgan
also
import
issu
well
possibl
diagnosi
directli
clinic
sampl
ms
method
current
use
viral
diagnosi
refin
technolog
import
approach
introduct
malditof
routin
viral
diagnosi
